Stocks News

LAST PRICE
8.7600
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
---/ ---
Ask / Lots
---/ ---
Open / Previous Close
--- / 8.7600
Day Range
---
52 Week Range
Low 5.8500
High 26.3789
Volume
---
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 18, 2024
- DJ CervoMed Initiated at Buy by D. Boral Capital, from 10:25AM ET on Monday Nov 18, 2024 by Dow Jones
  10:25AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: CRVO
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CRVO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 18, 2024 10:25 ET (15:25 GMT)
Nov 14, 2024
- DJ CervoMed Is Maintained at Buy by Chardan Capital, from 5:48PM ET on Thursday Nov 14, 2024 by Dow Jones
  5:48PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: CRVO
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CRVO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 14, 2024 17:48 ET (22:48 GMT)
Nov 13, 2024
- CervoMed Announces Key Senior Leadership Appointments, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
  8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: CRVO
  
  CervoMed Announces Key Senior Leadership Appointments
  
  New hires in key scientific and regulatory roles to advance continued development of neflamapimod
  
  BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today reported two senior leadership appointments to advance continued development of neflamapimod.
- Press Release: CervoMed Announces Key Senior Leadership Appointments, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
  8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: CRVO
  
  CervoMed Announces Key Senior Leadership Appointments
  
  New hires in key scientific and regulatory roles to advance continued development of neflamapimod
  
  BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today reported two senior leadership appointments to advance continued development of neflamapimod.
Nov 12, 2024
- Sidoti Events, LLC's Virtual November Micro-Cap Conference, from 8:31AM ET on Tuesday Nov 12, 2024 by Dow Jones
  8:31AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: GAIA, GIFI, NATR, CRVO, SLVR, OWLT, IRMD, ANIX, ZOM
  
  NEW YORK, NY / ACCESSWIRE / November 12, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day November Micro-Cap Conference taking place Wednesday and Thursday, November 13-14, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

Yesterday
- Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States, from 21 hours ago by Dow Jones
  21 hours ago by Dow Jones
  Companies Mentioned: CLSD
Nov 19, 2024
- Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting, from 7:00AM ET on Tuesday Nov 19, 2024 by PR Newswire
  7:00AM ET on Tuesday Nov 19, 2024 by PR Newswire
  Companies Mentioned: ARMP
- Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting, from 7:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  7:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: ARMP
Nov 15, 2024
- DJ Clearside Biomedical Is Maintained at Buy by Chardan Capital, from 5:52PM ET on Friday Nov 15, 2024 by Dow Jones
  5:52PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: CLSD
Nov 14, 2024
- DJ Armata Pharmaceuticals Price Target Maintained With a $7.00/Share by HC Wainwright & Co., from 1:24PM ET on Thursday Nov 14, 2024 by Dow Jones
  1:24PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: ARMP
- DJ Clearside Biomedical Price Target Maintained With a $6.00/Share by HC Wainwright & Co., from 4:57AM ET on Thursday Nov 14, 2024 by Dow Jones
  4:57AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: CLSD
Nov 13, 2024
- Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update, from 4:05PM ET on Wednesday Nov 13, 2024 by PR Newswire
  4:05PM ET on Wednesday Nov 13, 2024 by PR Newswire
  Companies Mentioned: ARMP
- Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
  4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: ARMP
- *DJ Armata Pharmaceuticals 3Q Loss/Shr 15c >ARMP, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
  4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: ARMP
- DJ Clearside Biomedical Price Target Maintained With a $6.00/Share by Needham, from 6:56AM ET on Wednesday Nov 13, 2024 by Dow Jones
  6:56AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: CLSD

CervoMed Inc
NASDAQ:CRVOUnited States

Search Criteria

Nov 18, 2024

DJ CervoMed Initiated at Buy by D. Boral Capital, from 10:25AM ET on Monday Nov 18, 2024 by Dow Jones

Nov 14, 2024

DJ CervoMed Is Maintained at Buy by Chardan Capital, from 5:48PM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

CervoMed Announces Key Senior Leadership Appointments, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones

Press Release: CervoMed Announces Key Senior Leadership Appointments, from 8:00AM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 12, 2024

Sidoti Events, LLC's Virtual November Micro-Cap Conference, from 8:31AM ET on Tuesday Nov 12, 2024 by Dow Jones

Peers Headlines

Yesterday

Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States, from 21 hours ago by Dow Jones

Nov 19, 2024

Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting, from 7:00AM ET on Tuesday Nov 19, 2024 by PR Newswire

Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting, from 7:00AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 15, 2024

DJ Clearside Biomedical Is Maintained at Buy by Chardan Capital, from 5:52PM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

DJ Armata Pharmaceuticals Price Target Maintained With a $7.00/Share by HC Wainwright & Co., from 1:24PM ET on Thursday Nov 14, 2024 by Dow Jones

DJ Clearside Biomedical Price Target Maintained With a $6.00/Share by HC Wainwright & Co., from 4:57AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update, from 4:05PM ET on Wednesday Nov 13, 2024 by PR Newswire

Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones

*DJ Armata Pharmaceuticals 3Q Loss/Shr 15c >ARMP, from 4:05PM ET on Wednesday Nov 13, 2024 by Dow Jones

DJ Clearside Biomedical Price Target Maintained With a $6.00/Share by Needham, from 6:56AM ET on Wednesday Nov 13, 2024 by Dow Jones